BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
BMY.RT
Delisted
BMY.RT was delisted on the 31st of December, 2020.
4 hedge funds and large institutions have $0 invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
Holders
4
Holders Change
-4
Holders Change %
-50%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
1 |
JCI
1
Jet Capital Investors
New York
|
$0 |
2 |
2
Tudor Investment Corp
Stamford,
Connecticut
|
$0 |